Antisense composition and method for treating muscle atrophy
First Claim
1. An antisense morpholino oligonucleotide of 15-40 bases, comprising a base sequence that is complementary to at least 12 contiguous bases of SEQ ID NO:
- 6, wherein the antisense morpholino oligonucleotide inhibits the expression of human myostatin in a cell, and wherein the antisense morpholino oligonucleotide comprises phosphorus-containing intersubunit linkages, in accordance with the structure;
3 Assignments
0 Petitions
Accused Products
Abstract
A method and compound for treating skeletal muscle mass deficiency in a human subject are disclosed. The composition is an oligomer of morpholino subunits and phosphorus-containing intersubunit linkages joining a morpholino nitrogen of one subunit to a 5′ exocyclic carbon of an adjacent subunit, contains between 10-40 nucleotide bases, has a base sequence effective to hybridize to an expression-sensitive region of processed or preprocessed human myostatin RNA transcript, identified, in its processed form, by SEQ ID NO: 6, and is capable of uptake by target muscle cells in the subject. In practicing the method, the compound is administered in an amount and at a dosage schedule to produce an overall reduction in the level of serum myostatin measured in the patient, and preferably to bring the myostatin level within the a range determined for normal, healthy individuals.
-
Citations
11 Claims
-
1. An antisense morpholino oligonucleotide of 15-40 bases, comprising a base sequence that is complementary to at least 12 contiguous bases of SEQ ID NO:
- 6, wherein the antisense morpholino oligonucleotide inhibits the expression of human myostatin in a cell, and wherein the antisense morpholino oligonucleotide comprises phosphorus-containing intersubunit linkages, in accordance with the structure;
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
- 6, wherein the antisense morpholino oligonucleotide inhibits the expression of human myostatin in a cell, and wherein the antisense morpholino oligonucleotide comprises phosphorus-containing intersubunit linkages, in accordance with the structure;
Specification